Hydrocortisone butyrate

丁酸氢化可的松

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameHydrocortisone butyrate
Drug Alias NameHydrocortisone 17α-butyrateHydrocortisone, Butyrate d’Butirato de hidrocortisonaHydrocortisoni ButirasCortisol Butyrate +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPruritusEczemaDermatitis, Seborrheic +[7] 
Global Approved IndicationsPruritusEczemaDermatitis, Seborrheic +[6] 
Approved Indications in ChinaPruritusEczemaDermatitis, Seborrheic +[4] 
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesSerbiaIreland +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center ZvezdaraHikma PharmaceuticalsPrecision Dermatology Inc +[6] 
Inactive CompaniesDs Biopharma Ltd
Active IndicationsPruritusEczemaDermatitis, Seborrheic +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeD07AB02
Related LinksWikipediaDrugBankKEGG